Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Nanotechnology Drug Delivery Market to reach US$ 11.9 Bn in 2023

Transparency Market Research
Posted on: 06 Oct 16

A great deal of active research into medical technologies has fetched many new ways of drug delivery. Currently, nanotechnology as a drug delivery technique holds a promising position in the healthcare and medicine market. Nanotechnology is already being used in cosmetics and sunscreens. The future applications of nanotechnology promise a lot more. Going forward, it is quite possible that some of the noticeable changes in our daily life could be because of nano-medicine. Some of the possibilities of nano-medicine might be nanoformulations for drug delivery, nano-robots, and engineered microbes. 

Recently, researchers at the MIT and Brigham and Women’s Hospital developed a new nanotechnology drug delivery method that directly delivers anti-obesity drugs to fat tissues. The drug transforms white adipose tissues into brown adipose tissues, which burns body fat. This new drug-delivery approach is expected to hold the potential to treat obesity without any side effects on other body parts.

Get a Sample of Research Report:

Stem cell nanotechnology is used in medicine for its growing application in tissue repair and as a regenerative medicine. Microencapsulation and nanotechnology have been used as a means of protecting cells from innate immune responses. 

Experts from Transparency Market Research state that the global nanotechnology drug delivery market is set to expand at a 12.50% CAGR from 2015 to 2023. TMR experts answer a few important questions related to the global nanotechnology drug delivery market:
Q. What would make Europe the biggest contributor to the global nanotechnology drug delivery market in the near future? 

A. Scientists from Europe have been involved in the discovery of new nanotechnology drug delivery methods. As per Eurostat data, the nanomedicine industry in Europe comprises 64 SMEs, 97 startups, and 38 large-scale pharmaceutical companies. With increasing technological advancements, nanotechnology drug delivery in Europe is expected to grow rapidly, which is why Europe is one of the biggest contributors to the global nanotechnology drug delivery market. 

Nanotechnology is expected to have a positive impact on health monitoring, drug delivery, diagnosis, research and development, tissue repair, and gene therapy. Currently, in Europe, healthcare professionals are using stem cell nanotechnology drug delivery method to treat type 1 and type 2 diabetes. 

Q. Are there any factors which would hold back the growth of the global nanotechnology drug delivery market?

A. Yes, stringent government regulations and the high cost of development of new drugs through nanotechnology are two of the primary factors expected to hamper the growth of the global nanotechnology drug delivery market. Other unknown limitations of newly introduced nanotechnology drug delivery methods also might hamper the growth of the global market. 

For instance, at Northwestern University, researchers recently developed nanostars for drug delivery. These nanostars have the capacity to deliver drugs directly to the cancer cells. Researchers found out that the drugs could not be delivered to the cancer cells as the body broke down during the procedure. This is a drawback, which the scientists believe they can overcome someday. 

Q. Which nanotechnology drug delivery segment dominates the global market and why?

A. Nanocrystals, liposomes, nanotubes, nanoparticles, and micelles are some of the technologies widely used in the global market. Among the many drug delivery technologies available, the nanoparticles segment dominated the global nanotechnology drug delivery market. The growing use of nanoparticles such as gold nanoparticles, fullerenes, and dendrimers for pharmaceutical drug delivery is predicted to propel this segment. However, the nanotubes segment is expected to register the highest CAGR in the years to come.

Moreover, with many new products lined up for a release, the global nanotechnology drug delivery market is expected to witness significant growth in the next few years.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Editor's Details


Last updated on: 06/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.